Therapy-Related Myelodysplastic Syndrome (DBCOND0079186)
Identifiers
- Synonyms
- Therapy-related myelodysplastic syndrome / Therapy-related myelodysplastic syndrome (disorder)
Associated Data
- Indicated Drugs and Targets
- Not Available
- Clinical Trials
Identifier Title Drug(s) Purpose Phase Status NCT05292664 Venetoclax Basket Trial for High Risk Hematologic Malignancies treatment 1 recruiting NCT02727803 Personalized NK Cell Therapy in CBT treatment 2 recruiting NCT02658487 Vosaroxin and Infusional Cytarabine in Treating Patients With Untreated Acute Myeloid Leukemia treatment 2 active_not_recruiting NCT01823198 Donor Natural Killer Cells and Donor Stem Cell Transplant in Treating Patients With High Risk Myeloid Malignancies treatment 1 / 2 completed NCT01619761 NK Cells in Cord Blood Transplantation treatment 1 unknown_status NCT04160052 Venetoclax and Azacitidine for the Treatment of High-Risk Recurrent or Refractory Myelodysplastic Syndrome treatment 1 / 2 recruiting NCT04550442 Venetoclax and Azacitidine for the Treatment of Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia treatment 1 / 2 recruiting NCT05379166 Venetoclax and Azacitidine for Treatment of Therapy Related or Secondary Myelodysplastic Syndrome treatment 2 recruiting NCT03359460 Ibrutinib and Lenalidomide in Treating Patients With Myelodysplastic Syndrome treatment 1 completed NCT01885689 Clofarabine and Melphalan Before Donor Stem Cell Transplant in Treating Patients With Myelodysplasia, Acute Leukemia in Remission, or Chronic Myelomonocytic Leukemia treatment 2 active_not_recruiting NCT05316701 Precision-T: A Randomized Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies No drug interventions treatment 3 active_not_recruiting NCT03272633 Irradiated Donor Cells Following Stem Cell Transplant in Controlling Cancer in Patients With Hematologic Malignancies No drug interventions treatment 0 terminated NCT03096782 Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or Lymphoma treatment 2 completed NCT02960646 Engineered Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies treatment 1 completed